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The Effect of Antibiotic and Resistance Education on Patient 
Knowledge
Abstract
Our society, which has enjoyed the benefits of antibiotics for over fifty years, is now 
experiencing an increase in bacterial resistance. One contributing factor is a lack of patient 
understanding about antibiotics resulting in their inappropriate usage. This study examined 
the effect of patient education in antibiotics and bacterial resistance on patient knowledge.
Adults from various medical facilities (a student health services clinic, an urgent care 
office, a family practice, and a community convenience sample) were given a ten-question 
survey designed to assess their knowledge of antibiotics and resistance. Half o f the 
participants were randomly given an educational brochure to read before taking the survey, 
the other half received the survey and the brochure.
The control group contained 34 subjects and had a mean score of 9.00 with 1.371 for 
the standard deviation. The experimental group contained 31 subjects with a mean score of 
9.77 and .425 for the standard deviation. The t-test statistic was -3.132 with a P value of 
.0015. The control group answered 36 questions incorrectly in comparison to 6 in the 
experimental group.
This demonstrated the effectiveness of patient education on patient knowledge of 
antibiotics and bacterial resistance.
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Chapter 1 
INTRODUCTION
Our society has enjoyed the benefits of what most physicians would call the wonder 
drug. For the last 56 years since the antibiotic penicillin was first used, bacterial assaults 
on us have been controlled, diminished, and cured. The great power of the antibiotic, 
however, is failing. This failure is due to what has been called an international public 
health nightmare; increasing bacterial resistance to many antibiotics that once cured 
bacterial diseases readily.* In other words, the antibiotic is unable to destroy the bacteria. 
Diseases that are hardly considered as a problem have the potential to become dangerous, 
and perhaps even deadly.
Since antibiotics were first introduced, it was noticed that some bacteria would not 
respond to them. Bacterial resistance has always been around. Resistance genes pre­
existed in nature, in soil, and water, and their presence was probably related to the 
production of antibacterial agents, synthesized naturally in the environment.^ Today, 
resistance is gained either by intrinsic methods, or acquired methods. Intrinsic resistance, 
as defined above, is present naturally, and acquired resistance occurs when bacteria 
exposed to an antibiotic develop a mechanism to overcome the activity of that antibiotic.^ 
Bacterial exposure to antibiotics has soared. In 1954, 2 million pounds of antibiotics were 
produced in the U.S. In 1998 more than 50 million pounds were produced. * The bacteria, 
due to such high exposure, have developed several strategies of resistance. These include 
the ability to pump out antibiotics that get inside them, making enzymes that deactivate the 
drugs, and changing themselves so the drug cannot bind and work.'* The bacteria have 
responded brilliantly to our arsenal of drugs. These mechanisms account for almost every
disease-causing bacterium to have developed resistance to one or more of the 150-plus 
antibiotics in use today/
Many are now calling for strategies to combat this worldwide problem. It has been 
suggested that new classes of antibiotics need to be developed, tighter regulations for 
veterinary and agricultural uses of antibiotics be defined, doctor prescribing practices be 
changed, and antibiotic and resistance education for health care providers and patients be 
implemented. The area of patient education is one of great importance. Patients often seek 
medical attention for viral illnesses. In fact, upper respiratory infections, (the common 
cold), is one of the five most common diagnoses in ambulatory care physician oftice 
visits.  ^ In 1997, 818 billion prescriptions were written for respiratory tract infections, 
totaling approximately 75% of all prescriptions written worldwide.® Furthermore, these 
respiratory illnesses have been caused by a virus in more than 90% of the cases. ^  
Antibiotics do not work against viruses.
This author believes the problem is that patients do not have a good understanding 
of antibiotics or bacterial resistance. This lack of knowledge most likely plays a role in the 
widespread use of antibiotics. This author believes that a greater understanding of 
antibiotics is necessary for patients to try other avenues of coping with their viral illnesses. 
An awareness of the resistance problem could be a motivation for lessening the desire for 
antibiotics. Increasing their knowledge may aid in the strategies to reverse bacterial 
resistance.
Several other contributing factors have been identified as furthering bacterial 
resistance. Antibiotics are extremely overused. It is estimated that up to 75% of all 
antibiotic use is questionable.^ Of those prescriptions written, many are for broad-spectrum
antibiotics. These drugs promote resistance because they work on a broad range of 
bacteria. Furthermore, doctors admit to being bothered by giving antibiotics to misguided 
patients against their own better judgement. The following is a typical interaction as 
described by a physician:
A patient comes to the doctor with an iniection he thinks is sinusitis and the 
medical exam is questionable. It could be caused by bacteria, virus or allergy. You tell the 
patient to get some decongestant nasal spray. But die patient feels the visit has beai 
useless, and he might say, ‘well, last year 1 had this same problem, and Dr. X gave me 
amoxicillin and it went right away.’ Because the physician doesn’t  want to lose the patient, 
or maybe out of genuine sympathy, 1 sometimes succumb, and my colleagues do, too. The 
patient is dictating which antibiotics we give him.'*
Another area of overuse is in agricultural settings. Farmers spray large areas of 
fruit trees with antibiotics to ward o ff potential diseases in the fruit. Animals are given 
antibiotics in their feed to promote growth, although this benefit has not been proven. Both 
of these practices can encourage the growth of resistant bacteria. These bacteria then can 
make their way into people through the food chain. How much resistant bacteria do we 
consume? Levy cites a study of human volunteers who ate only bacteria-free foods. The 
number of resistant bacteria in their feces decreased 1000-fold. * This suggests that we are 
ingesting significant amounts of resistant bacteria.
To further spread the resistant strains throughout the community, our cultural 
choices play a part. Today we crowd the most vulnerable members of society in day care 
centers and nursing homes.^ These people are the most susceptible to acquiring and 
spreading a resistant strain.
Finally, overuse is also seen in the new wave of consumer products. Antibacterial 
soaps and cleaners have flooded the market and most homes. These provide for more
opportunity of bacterial exposure to antibacterial agents, and consequently increase the 
chance of breeding drug resistant bacteria.
The purpose of this study is to examine the effects of antibiotic and bacterial 
resistance education on patient knowledge. The results may show that patients presented 
with information on antibiotics and drug resistance have more knowledge about these 
subjects than patients who do not receive the information. This study is designed to gather 
data on patient knowledge in the Grand Rapids area. Other studies have been conducted in 
other areas of the country. The results should reveal a greater understanding for health care 
providers in dealing with their patients in antibiotic therapy. It is undeniable these are 
complex behaviors. Patients leam to associate recovery from illness with antibiotics, and 
expect the same treatment on subsequent ofSce visits. Doctors seek to satisfy their patients 
and give the prescriptions. However, if patient demand decreases due to an increased 
understanding, doctor-prescribing practices should follow suit.
The author feels this study is significant because a bleak antibiotic future exists. 
Patient education, as one component, becomes more important. Any decrease in the 
overuse of antibiotics certainly is not only viewed as beneficial, but necessary. Bruce 
Levin, a researcher in bacterial resistance states, “we may be stuck with what we have 
sown. It’s not clear to me that we can even slow down this process of evolving 
resistance.”’
My hypothesis states that patients who are given adequate education on antibiotics 
and the bacterial resistance problem will gain knowledge in these areas. It is the hope of 
the author, that although beyond the scope of this paper, the patients will use that 
knowledge in changing their expectations for receiving antibiotics in the future.
Chapter 2 
LITERATURE REVIEW 
Most of the literature read was 6om professional journal articles. Other sources 
included newspaper articles and Internet sites. In reviewing these, several main subjects 
became apparent. These subjects form the organizational basis for this chapter. Within 
these subjects, prominent themes also emerged. These were analyzed and discussed.
Antibiotics and the Resistance Problem 
Most articles were in agreement that there is a very real, and serious threat 
emerging in health care. Levy, a prominent authority on the subject stated, “we’re in the 
midst of a crisis, we have to change things.”^  In Denmark, the chief medical oflBcer called 
colleagues form the European Union for a conference on the microbial threat to assess 
strategies to prevent and control emergence and spread of antimicrobial-resistant 
organisms. He addressed the gathering with, “a nightmare scenario of multi-drug resistant 
bacteria laying waste the human race in the next millennium is a real possibility. If we 
don’t make serious attempts to address this issue, it won’t matter that we have antibiotics in 
20 years time; they simply won’t work. We are running out of time and need to act now.”‘“ 
Antibiotic resistance is not a new phenomenon. Since the introduction of penicillin, 
bacteria have been noted to express some resistance. This resistance almost always follows 
the introduction of new drugs. It is the frequency of resistance that is currently observed 
which causes alarm. Two main forces determine whether bacteria become resistant. These 
are I) prevalence of resistance genes, and 2) the extent of antibiotic use. To understand the 
genetics of resistance, Burk, Canales, Rahr and Ayachi cited that for Mycobacterium 
tuberculosis, resistance occurs spontaneously in approximately I in 100,000-1,000,000 
bacilli.”
Most authors, however, focused on the overuse of antibiotics. It is this use which 
allows 0 q)osure of the bacteria to the drug and promotes resistant strains. Hafeez ,^ Saltust 
Perreten et ai'’*, Cohen, Rex, and Anderson^^ and Wise et al^  all recognize that antibiotics 
are overused and misused on a global scale. One specific area of overuse is upper 
respiratory infections and bronchitis. Viruses most often cause these illnesses. Gonzalez, 
Steiner, and Sande studied the antibiotic misuse problem in this area. They found that 
prescribing antibiotics for viral illness is broad based, spanning a wide geographical area 
and range of medical specialties, and varies little with sociodemographic or financial 
characteristics.^ Wise et al agrees that “in the past 50 years people worldwide have 
accepted antibiotics as their right to get a prescription at the first sign of a trivial 
infection.”* How serious is this problem? Radetsky points out that over 2 million people 
contract bacterial infections in the hospital, where some 90,000 die. Approximately 70% 
of these are infected by drug resistant bacteria.^ It is believed that if exposure to an 
antibiotic is decreased or stopped, the future bacterial generations will revert back to being 
susceptible. This evidence is inconclusive. Morell cites a study where over a 10-year 
period, 20,000 generations of bacteria were cultured and studied to observe resistant strains 
converting back to being susceptible strains. The bacteria never reverted back to being 
susceptible.*^
Besides taking antibiotics and promoting resistant strains in our bodies, humans 
pick up resistant bacteria in other ways. Levy conducted a study that shows that when I 
member of a household chronically takes an antibiotic to treat acne, the concentration of 
antibiotic resistant bacteria on the skin of family members rises.*
There were contradictory articles reviewed as well. Bergogne^ and Bax et al‘® all 
disagreed with the idea that antibiotic use is the main cause of bacterial resistance. Bax et 
al goes as far to say that '*the problem is incompletely understood and there is not enough 
evidence to support specific prescribing or control policies.”** Bergogne places more 
emphasis on the genetic factors of the organism involved and intrinsic resistance.
Contributing Factors 
Although causes to the resistant problem have been mentioned, these articles 
focused sole attention on contributing factors. Ackerman'* ,^ Eden***, and Kunin*  ^all listed 
increased antibiotic use and dosages as significant. Kunin believes that “the opportunity to 
prolong the effective life of each new antimicrobial drug by more appropriate use was 
squandered by excessive use.”*^  The underlying cause for this excessive use was seen as 
unnecessary prescribing by physicians. Monmaney writes that doctors are partly to blame. 
In a survey of 1500 physicians with 29,000 patient visits, more than half with a cold or 
upper respiratory infection got an antibiotic, or 1 in 5 prescribed antibiotics for conditions 
they don’t help.*  ^ Gonzales, Steiner, and Sande agreed and place blame on doctors. They 
revealed that despite sufficient data, (7 randomized double-blind studies), showing no 
major clinical role for antibiotics in uncomplicated acute bronchitis, practitioners continue 
to prescribe at an alarming rate.^ In an in depth look at prescribing practices, Belongia and 
Schwartz quoted a widely held physician’s sentiment, “to write prescriptions is easy, but to 
come to an understanding with people is hard.”**
The physician prescribing habits can be further understood when patient 
expectations are taken into account. Gonzales states that physicians surveyed about 
antibiotic prescribing list patient pressure as a main reason fbr giving them.^* Treese agreed
with the patient expectation problem'*’ and Butler et al gave a clearer understanding of 
patient and doctor thoughts. In a qualitative study on patient and doctor perceptions, 
doctors found changing patient beliefs and expectations to be time consuming and 
unrewarding. Most doctors did try to explain that antibiotics do not work against viruses, 
but the patients were confused and did not understand. Of all the patients surveyed, 1/3 
had a clear expectation of receiving antibiotics. One patient said, “I know what I want; 
speed is essential. I have to get pen ic i l l in . I t  seemed to be a cycle where the patient 
wanted antibiotics, so the doctor prescribed them. This was reinforced each time the 
patient was sick and saw the doctor.
One article disagreed somewhat with the others. Smaglik placed equal 
responsibility for overprescribing on patients and a health care system that emphasizes 
treatment over education.^ He placed emphasis on education of both patients and doctors.
Patient Knowledge
The third subject seen in the literature was what patients know about taking drugs. 
This area was found to be the least studied. Patient knowledge actually is related to and 
affects other factors such as compliance, attitudes, and behaviors. Kunin et al determined 
specific patient beliefs about antibiotics. They pointed out current thinking which includes 
a pill for every ill, antibiotics are a wonder drug able to heal a wide variety of illnesses, and 
antibiotics are faster than other agents.^  ^ This particular study showed great significance 
due to the fact that world populations were studied. Mainous et al also examined specific 
beliefs about antibiotics and upper respiratory infections. They concluded that patients 
lack understanding of the normal presentation of upper respiratory infections and antibiotic
effects as treatment. They further stated that this lack of knowledge may play a role in the 
widespread use of antibiotics for illnesses they won’t help.^
Patient Use/Behavior
Patient knowledge has a direct influence on patient use and behavior concerning 
antibiotics. This can be seen in a study conducted in Spain, which sought to find how 
prevalent household antibiotic storage was. Of 1000 households, 42% contained 1 or more 
antibiotics. Only 19% had a person in the house currently under physician care with 
antibiotics.^  ^ This showed an obvious misuse of antibiotics. Patients thought it was 
perfectly acceptable to keep some for later use.
The remaining articles discussed patient compliance. Compliance is the patient’s 
adherence to a drug regimen. Patient non-compliance rates have been measured and 
studied. Morris and Halperin reported non-compliance rates ranging form 30-80%, and 
blamed failure of communication between the health care provider and patient.German 
et al supported communication especially for elderly patients. In a study conducted on 
people over 65, they concluded that they were more likely to be correct about the action 
and purpose of their drugs and to comply with prescribed regimens when they perceived an 
ongoing state of communication with their health care providers.^^ When asked directly 
why they might be noncompliant, 4/5 of the patients in a study by Donovan and Blake said 
they dislike having to take drugs at all.^ “ Articles by Stephenson et al and DiMatteo 
expressed the same reasons. The patients believe the regimens are inconvenient, 
embarrassing, and impractical. '^"^^
Solutions
To address the resistance problem, most articles were studies done to show the 
effectiveness of trial solutions. Carbon and Bax outlined two different programs, both 
based on removing certain antibiotics from use or greatly decreasing their use.  ^ The first 
was conducted in Iceland where a nationwide campaign against inappropriate antibiotic use 
was begun after a multi-drug resistant strain of 51 pneumoniae seen. Once antibiotic 
consumption started to decline, pneumococcal resistance also started to decrease as tested 
by nasopharyngeal carriage in day care centers. The second successful trial occurred in 
Finland. A national recommendation to reduce the use of macrolide antibiotics was issued. 
This was done because of a resistant strain of group A streptococcus to erythromycin. 
Erythromycin resistance peaked at 19% in 1993, then dropped to 8.6% in 1996. Both 
decreases in resistance were attributed to regulation of antibiotic use. A direct 
contradiction to these findings was described by Morell,'^ as mentioned earlier. Reducing 
or eliminating the antibiotic did not reverse the effects and resistant strains remained.
Roter and Hail viewed the doctors as the solution. They suggested comprehensive 
discussion to explain treatment to patients and motivating patients to adhere to treatments. 
These were outlined with specific objectives and examples of what the health care 
providers should say.^  ^ Cohen, Rex and Anderson also placed responsibility with 
physicians. In the case of a viral respiratory infection, they believe a straightforward 
explanation of why, given clinical findings, an antibiotic is unlikely to be useful. For those 
patients who still demanded an antibiotic prescription, they suggested to give it but with 
patient instructions to call the office after 48 hours to find out whether or not to fill it.^ '^  
Realizing the direct influence physicians have in antibiotic use, LDS Hospital in Utah
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conducted a trial program and subsequent study into the results/^ A bedside computer 
system was installed to help physicians select the most appropriate antibiotics for 
hospitalized patients. Computer terminals and monitors were placed in every patient room 
and each clinical area. These terminals were linked to a hospital-wide database and 
decision support program. In a 7-year, 160,000 patient study, they found several benefits. 
These were that antibiotic use decreased by 22.8%, mortality rates decreased fi'om 3.65% 
to 2.65%, antibiotic associated adverse drug events decreased 30%, antibiotic resistance 
patterns remained stable, the percentage of surgical patients who received appropriately 
timed pre-operative antibiotics increased form 40% to 99.1%, antibiotic cost per patient 
decreased fi’om $122.66 to $51.90, and total antibiotic acquisition costs decreased fi'om 
24.8% to 12.9%. This article focused on improving doctor use of antibiotics over 
restricting doctor use of antibiotics.
Another solution, although limited to only one article, was new drug development. 
Glausiusz found a relatively new pharmaceutical company developing the next generation 
of antibiotics firom a compound found in frog skin, salamanders, snakes, sharks, and honey 
bees.^  ^ The compound has been called magainin and shows great promise. It functions 
against bacteria differently than other classes of drugs. There are, however, hurdles to 
overcome as with any new drug. Glausiusz quotes the CDC, “every year we see poster 
after poster of new drugs, some totally synthetic, some natural products, that inhibit wide 
ranges of bacteria at very low concentrations. But 3 years later they’re never heard of 
again because they’re either too toxic or cause significant side effects, or trigger an 
immune response. It’s hard to look into the crystal ball and say these really are the future 
of antibiotic therapy... Overall, the discovery and development into new classes of
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antimicrobial drugs active against drug resistant organisms has slowed. Wood, Gold and 
Moellering explained that cost is a major reason for this. It currently costs approximately 
$300 million to bring a new drug to market. Radetsky added that an informal survey of 
pharmaceutical companies in the U.S. and Japan showed at least 50% of them had either 
diminished greatly or completely gotten out of antibiotic research.^
Huovinen and Cars specifically listed targeting diagnosis and treatment of 
respiratory tract infections and other viral illnesses, and improving public knowledge of the 
risks and benefits of antibiotic therapy.'^ There is an organization, the Alliance for Prudent 
Use of Antibiotics which is actively involved in the resistance problem. They are an 
international grassroots organization with members in more than 90 countries. They 
specifically promote global public health in antibiotic resistance through education of 
health care personnel and patients, via conferences, publications, and research.''*
Finally, almost all articles listed patient education as a necessary addition to 
solutions. To begin the review on this topic, a quote from the Joint Commission on 
Accreditation of Health Care organizations was offered by Bernier “the patient and /or 
when appropriate, his/her significant others are provided with education that can enhance 
their knowledge, skills, and those behaviors necessary to fully benefit from the health care 
interventions provided by the organization.”^^  Collier called this "the patient’s right to 
education." He adopts the WHO’s principle whereby patients need this information to 
allow them to decide whether they want to receive the therapy. ’^ Avora et al expanded on 
the subject by including other factors. They believe that the disciplines of anthropology 
and sociology need to be applied to studies of patients’ perceptions of what illnesses 
require antibiotic therapy. Further, more needs to be learned about epidemiology of correct
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and incorrect beliefs and how such beliefs vary across cultures and across strata within 
cultures/^ As an example of this, DiMatteo discussed social science research on 
physician-patient relationships. He asserted that >90% of patients want as much 
information about their health care as their physicians are willing to provide.Micelli et al 
agreed and pointed out that the desire for simple, understandable straightforward 
educational messages is impressive in that it was shared by the wide majority regardless of 
age, sex, degree of education and geographic location.^
Further benefits of patient education were listed by Bernier. They are one of the 
most economical and effective instructional mediums available.^^ Tumridge rested all 
other solution strategies on patient education. He goes as far to say that none (solution 
strategies) will work until the public is better educated in infectious diseases and the role of 
antibiotics, and the difference between a virus and bacteria."**
Finally, the literature gave guidelines on how to write more effective patient 
education materials. Obviously, the materials are only useful if patients can read and 
understand them. Mumford explained that many leaflets are written at the university or 
post-graduate level."*^  This article explained ways to design educational materials at 
appropriate grade levels. Miselli et al conceded that the information available to the public 
is the result of a trade off between technical jargon and commercial promotion."*®
The remaining articles were actual examples of educational information for the 
patient regarding antibiotics and resistance. They were available for reproduction without 
specific permission required. The first was titled “The Right Way to Use Antibiotics.”^^  It 
consisted of 10 questions and answers, along with some definitions. The second was “You, 
Your Family and Antibiotics; The Untold Story.”"*"* This was also a question and answer
13
format but with only 6 questions. The last «campie was from The Alliance for the Prudent 
Use of Antibiotics.'*  ^ This was a very lengthy question and answer document. This 
information is freely accessible and encouraged to be used in part or completely.
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Chapter 3 
RESEARCH METHOD
Much emphasis has been placed on patient education as one solution to the 
problem of bacterial resistance to antibiotics. This investigation was based on the need to 
address patient understanding of antibiotics and bacterial resistance. As stated by Wise et 
al, “patients must be educated that most such infections (upper respiratory) do not require 
antibiotics.”  ^Patient education is one of the most significant yet most bypassed aspect 
regarding bacterial resistance. It is also one of the simplest and most economical 
solutions. Patients acquiring knowledge in these areas will have important implications 
fbr the worldwide problem of bacterial resistance.
My hypothesis stated that a simple educational tool in the form of a brochure 
would increase or add to patient knowledge in the area of antibiotics and bacterial 
resistance. To test this, a research design was needed that determined what patients know 
without the aid of the education, and what they know after reading the educational 
material. It was assumed that patient knowledge was consistent across the population and 
that most patients had a limited understanding of the information. Furthermore, because 
of this limited knowledge, they would seek medical attention and even demand 
antibiotics. It was also assumed that patient educational materials dealing with these 
problems were not being used. Finally, it was assumed that the questionnaire was 
sufficiently reliable to assess the patients’ knowledge.
Studv Design
The actual experimental design chosen was the classic design with an omitted pre­
test. The ecperimental design included random assignment of subjects to either a control
15
or experimental group. This was accomplished simply by alternating the patients as they 
came into the facility into the control group and then the experimental group. In the 
control group, subjects were given a ten-question survey, (Appendix A) which was 
designed to assess their knowledge of antibiotics and bacterial resistance. The subjects in 
the experimental group were first given a brochure (Appendix B) to read which explained 
the use of antibiotics and the development of antibiotic resistance. After reading the 
brochure, the experimental subjects completed the ten-question survey on antibiotic 
resistance.
This research project was reviewed and approved as a study given exempt status 
by the Grand Valley State University Human Research Review Committee. This 
document can be found in Appendix C.
Studv Site and Subjects
After approval from various locations, the subjects were recruited from four 
different sites. These sites were a family practice office, an urgent care fecility, a health 
service clinic, and a convenience sample from a community meeting. These sites were 
chosen to recruit a wide range of subjects who would be representative of the population.
The inclusion criterion fbr the subjects was adults aged 18 years to 65 years. 
Although the elderly population is a much needed research group, they were not sought 
as subjects due to frctors which may play a part in their lack of knowledge: re: age, 
illness, and difficulty in comprehensioiL Adults in the 18-65 year old group have been 
those seeking medical attention for viral illnesses, such as colds. It has been these 
patients who in the past have received antibiotics for a cold or acute bronchitis and now 
pair the resolution of their illness with the receipt of antibiotics.^ In one survey of
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patients in an ambulatory care practice, 60% of eligible patients, (those diagnosed with 
acute bronchitis), refused entry to a randomized controlled trial of antibiotics because 
they felt that antibiotics were absolutely necessary for their condition to improve.^" Most 
studies reviewed had targeted this age group as well.
Equipment and Instrumems 
Two different instruments were used. The first instrument used was a brochure, 
developed to educate the adult population on antibiotics and bacterial resistance. The 
brochure was the independent variable of the study and was carefully designed with a 
number of important guidelines in mind. These guidelines were taken fi'om literature 
describing successful patient education materials. Bernier outlined the SMOG formula 
for estimating the readability o f educational material.^  ^ The readability is computed by 
examining 30 sentences in the brochure. Ten are selected fi'om the beginning, 10 fi'om 
the middle and 10 near the end. The numbers of words with 3 or more syllables are 
counted in the 30 sentences (including repeated words). The nearest square root of the 3 
or more syllable words is determined and the number three is added. The final numerical 
value determines the grade level. For this brochure, the number of 3 or more syllable 
words was 58. The nearest square root of 58 is 7. Adding 3 gives a grade level of 10. 
The difficult terms in the brochure that caused this level were defined, thus improving the 
readability. The font size was at 13, as suggested by Bernier. The number of characters 
per line was kept between 50 and 70. Both upper and lower case letters were used to 
increase ease of reading. Bold print was used for headings and color was added to be 
pleasing to the eye. Main ideas were limited to 3, and active voice and pronouns were
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used to engage the reader. Finally, the information was written in a question and answer 
format to encourage learning. The brochure can be found in Appendix B.
The answers to the ten questions are addressed in the brochure. The second 
instrument used was a survey, which included a demographic section, followed by 10 
true or false questions regarding information on antibiotics and bacterial resistance. The 
demographic data included age, race, gender, occupation, education level, and annual 
income level. The questions were designed with the guidelines previously outlined. The 
survey tested the dependent variable, the subjects’ knowledge of antibiotics and bacterial 
resistance. The survey can be found in Appendix A.
Survev Response Rate
Of the 69 persons approached for participation, only 4 declined. Those who 
declined were all from the urgent care facility. Data was collected on 5 separate 
occasions, once at each location and twice at the urgent care facility in February and 
March.
Procedures
The procedure for data collection was simple and straightforward. To encourage 
consistency, one tester visited all 4 sites. As patients arrived for their appointment, they 
were approached and it was explained that a research project was being conducted in that 
facility that day. The tester informed the potential subjects that the project dealt with 
antibiotics. The subjects were then asked if they would be willing to participate in the 
study. If they agreed, the tester alternately assigned each to the control or experimental 
group. The control group received only the survey, while the experimental group 
received the brochure to read first, followed by the survey. The patients were told they
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could fill out the survey while they waited, as it would only take a few minutes. They 
were also told they could finish the survey when their appointment was over if they were 
called in. Due to the length of the questionnaire, most subjects were able to finish before 
being called in for their appointment. The surveys were collected, and subjects were 
thanked for their participation.
Data Analvsis
Both descriptive and inferential statistics were used. The individual scores, as 
number correct, were described using the mean, and standard deviation. This showed the 
central tendency and relative position of the data. The tests were also evaluated 
according to particular questions that were answered incorrectly. The demographic data 
collected was analyzed with fi'equencies and percentages. For inferential statistics, 
significant differences between control and experimental group scores were sought. An 
independent two samples t-test was done to compare the number correct of the 10 true or 
false questions between control and experimental groups. The scores of those not 
receiving the brochure, (control), compared to those receiving the brochure before taking 
the survey, (experimental), were studied. The hypothesis of the study stated that the 
experimental group would have higher scores in comparison to the control group.
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Chapter 4 
RESULTS
The target population was adults aged 18 to approximately 65 years of age. The 
sample was taken from this age group. Sixty-five subjects participated in the study. The 
sample consisted of 29 men and 36 women, with 62 being Caucasian, 2 African- 
American, and 1 Asian American. Their ages ranged from 18 to 69 with a mean age of 34 
years (standard deviation 13.12). For level of education, 40% had some college, 24.6% 
and 29.2% were high school and college graduates, respectively. Only 6.2% had not 
graduated from high school. Annual income levels ranged from less than $15,000 to more 
than $50,000 with the highest proportions in the under $15,000 level (28.6%) and the 
greater than $50,000 level (25.4%). More than half the respondents, 60.3%, made 
$35,000 per year or less. The demographic data is summarized in Table 1.
Table I
Demographic Characleiiatica of Sample 
Frequency Percent
Sex
Male 29 44.6
Female 36 33.4
Race -  - ----  —  ----
White 62 93.4
Non-White 3 4.6
A8B.Y 34
Meam+/-SD W- 13.12
' —  - -------------  - - - - ---------
<highacfaool 4 6Z
HS gradoate 16 24.6
Some college 26 40.0
College graduate 19 29Z
hKomc ■ -
<13,000 IS 28.6
13,001-23,000 9 143
23,001-33,000 11 173
33,000 -  30,000 9 143
>30,000 16 23.4
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My research hypothesis is that antibiotic and bacterial resistance education will 
increase patient’s knowledge in these areas. Sixty-five subjects were randomly divided 
into two groups. The control group contained 34 subjects; the experimental group 
contained 31. The mean test score for the control group was 9.0 with a standard deviation 
of 1.37. The mean test score for the experimental group was 9.77 with a standard 
deviation of .425. These statistics are summarized in Table 2. The collective scores of the 
control group and experimental group can be seen in the boxplot diagram of Figure 1.
Table 2 
T-Test Statistics
Gkoup N M en
Std.
Oevialiaa
Score
Control
Eaperimental
Score 
Equal variances 
no t assumed.
34
31
t
-3.132
9.000
9.774
Sig.(14ailed)
.0015
1J71
.423
104
Figure 1 
Collective Scores Plot
GROUP
si
UlO'
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A two independent samples t-test was performed. The t value was -3.132 with equal 
variances not assumed. The resulting P-value associated with the test statistic t of 
-3.132 was .0015. The data show sufficient evidence that antibiotic and bacterial 
resistance education increased patient’s knowledge.
In the control group, the question most often missed was number 4, (antibiotics are 
good medicine for colds or flu) with 12 participants out of 34 answering incorrectly. This 
was 35% of the respondents. The next most missed question was number 3 with 6 
answering incorrectly, or 18% of the respondents. Finally, number 2 had 5 answering 
incorrectly, or 15%. The total number of incorrect responses was 36.
In the experimental group, the question most often missed was number 8 (our 
society does not have a bacterial resistance problem) with 2 respondents out of 31 
answering incorrectly or .06%. This was followed by questions 2, 5,9, and 10, each with 
1 respondent answering incorrectly. The total number of incorrect responses was 6. The 
speciflc questions missed can be found in Table 3.
Table 3
Group Companson o f b co tred  Responses
Control Experimental
Question # Inooirect faoonect
_________________ Answers Answers___
1 3 0
2 5 1
3  6 0
4 12 0
5  1 1
6 0 0
7 2 0
8 4 2
9  0 1
10 3 1
Total 38 8
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In regard to the demographic data some significant differences in the control group 
can be noted. Those subjects with less than a high school diploma had the lowest mean 
with 7.5 and a standard deviation of .707. Also, those in the 30-39 age bracket scored a 
mean of 8.1 with a 2.27 standard deviation. The subjects that scored the highest (with 
perfect scores) were college graduates. The highest income bracket and oldest subjects 
(40-49 and 50-65) obtained mean scores of 9.6, SD .547,9.7, SD .516 and 9.7, SD .577 
respectively. The demographic data can be found in Table 4.
Table 4 
Scoring by Dem ogapbics
Control Standard Expcrim ertal S tm tard
bfean Score DeviHiaa hfaan Score D erâtica
Inoome
<15,000 9.00 1.00 930 J3 3
15.001 -25,000 8.40 li59 9.70 377
25,001 -35,000 9 J0 1.16 9.70 377
35,000 -  50,000 9.20 IJO 9.80................. 300
>50,000 9.60 .547 9.80 .405
Edncation
<higfi school 7 J0 .707 930 .707
HS graduate 8.70 1.92 9.70 .488
Som ecoU ^e 8.50 1.05 9.80 376  .....
College grad 10.0 0.0 9.8 .441
1 8 -29 8.80 1.07 9.80 .405
3 0 -3 9 8.10 2.27 9.60 335
4 0 -4 9 9.70 .516 10.0 0.0
5 0 -6 5 9.70 js n 10.0 0.0
Sex
Male 8.60 1.16 930 358
Female 9.20 1.47 9.60 .479
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Chapter 5 
DISCUSSION
It is well known that many physicians acquiesce to misguided patients who 
demand antibiotics to treat colds and other viral infections. This is estimated to account 
for 50 million of 150 million outpatient antibiotic prescriptions per year." One answer to 
this problem has been patient education.
While this study successfully interviewed patients with a wide range of incomes, 
education levels, and ages, there have not been other studies to compare with. Past 
studies have shown patient demand and subsequent receipt of antibiotics, but none have 
demonstrated what education can accomplish. The results of this study indicated that 
patients, when given educational material, will increase in their knowledge of the 
information given. Moreover, this need for antibiotic and resistance education may play 
a role in decreasing the widespread use of antibiotics for viral infections.
The statistical results were significant because they stated that if education did not 
increase knowledge, there was only a .0015 chance the data would have been obtained. 
This proved that education did increase the patients’ knowledge.
Implications
There are several implications of increasing patient knowledge of antibiotics and 
resistance. First, appropriate knowledge about antibiotics and the type of infection they 
work for should decrease office visits for viral infections such as colds or acute 
bronchitis. Surveyed patients already admitted associating their recovery from viral 
infections with antibiotics.^  ^ With upper respiratory infections accounting for 1 of the 5
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most common diagnoses in ofGce visits^, a decrease in these visits would have a large 
impact on the health care industry overall.
Second, patient expectations would be affected. Currently, patients have been 
programmed to expect antibiotics.^ They have even believed it is their right to get one. 
However, it has been pointed out that patients* expectations of antibiotic therapy may be 
in conflict with optimal medical guidelines for antibiotic use.^° Increasing their 
understanding of antibiotics would decrease their expectation for one, especially in the 
case of a viral infection. Furthermore, most doctors prescribed antibiotics simply because 
of patient demands and pressure. This would help those physicians who said they 
prescribed more than they would like to for these types of conditions.^
Third, because patient knowledge increased, a decrease in antibiotic use has 
implications in the widespread bacterial resistance problem. There has been general 
agreement that the best way to decrease selective pressure of antibiotics for bacterial 
resistance is to decrease antibiotic usage. Patient education advantages include, 
consistency of the message content, flexibility of delivery, portability, reusability, 
economical to produce and update, and permanence of the information.^^ Besides these 
benefits, patient education will break an established cycle of taking antibiotics for viral 
respiratory infections. This education needs to inform patients that past practices are no 
longer optimal. Belongia and Swartz believe that information given at office visits is 
immediately relevant and likely received as authoratative.** Another study called patient 
education an optimum strategy.^”
According to the data, a lower income level, age 30-39, and lower education level 
indicated less knowledge in the control group. The education level had greatest
25
significance on low mean score. Gender had no bearing on how much knowledge those in 
the control group had. No one characteristic affected the gaining of knowledge in the 
experimental group.
The test scores indicated a greater number of questions were missed altogether in 
the control group with 36 total incorrect answers. This is compared to the total number 
of questions missed in the experimental group with 6. To further assess patient 
knowledge, question number 4 was answered incorrectly, by 12 participants in the control 
group. This question read, “antibiotics are good medicine for colds or flu.” Patients 
generally believe this to be true. This is contrasted with the experimental group where no 
one answered this incorrectly. Again patient confusion about viruses and antibiotics 
appeared with question 3, the second most missed question. It read, “both viruses and 
bacteria can be cured by antibiotics.” Six of 34 in the control group and 0 in the 
experimental group missed this.
These results coincided with current literature detailing patient ideas about what 
illnesses benefit from antibiotics. These illnesses range from headaches in developing 
nations to viral upper respiratory infections in affluent suburbs of industrialized nations.^* 
Most patients are confused about antibiotics, bacteria, and viruses.
Validitv and Reliabilitv 
To address validity or truthfulness, both internal and external validity was 
considered. The internal validity, because of the nature of the study, was unaffected by 
history, maturation, testing, subject mortality and instrumentation. The only factor 
possibly affecting internal validity was a small convenience sample of subjects who were 
surveyed. These subjects volunteered and may have been different from the others who
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were selected. The external validity was not affected by most Actors. The 
generalizability was accounted for by random selection of participants.
The reliability may have been affected by subject motivation. Some of the 
participants were ill and not feeling particularly interested in much else than feeling 
better. The other factor that may have affected reliability was the environment. 
Distractions did occur, and occasionally, the subject was called in for their appointment. 
Those subjects finished their survey after their appointment was over.
Limitations
Two limitations to the study should be noted. First, the cross section of subjects 
as far as age, educational level, and income was wide, but the sample was not 
representative according to race. Although several sites were used for data collection, the 
experimental group consisted of all white participants. Therefore, the results of this study 
cannot be applied to non-white populations. Second, the survey used was not a 
standardized instrument. Standardized tests have undergone a normalizing process where 
their validity and reliability have been established against the normal populations.
Conclusions
This study confirmed the view that patient education has an effect on patient 
knowledge. It was shown to be an effective tool as one solution to the rising misuse of 
antibiotics for viral infections, and the subsequent bacterial resistance problem. Although 
this study was small, it encourages further studies into larger and different population 
groups. The lack of understanding displayed is evidence that quality educational 
materials on antibiotics and bacterial resistance should be utilized.
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Group:
Number
PATIENT SURVEY
Age:
Race;
Sex;
White
African American
Hispanic
Other
Male Female
Occupation:
Education: Less than High School Annual Income:
High School Graduate 
Some College 
College Graduate
Less than $15,000 
$15,001 to $25,000 
$25,001 to $35,000 
$35,001 to $50,000 
$50,000 or more
TRUE or FALSE  (circle one)
1. Antibiotics are prescription drugs that attack bacterial germs T F
2. Antibiotics work against all infections T F
3. Both viruses and bacteria can be cured by antibiotics...................T F
4. Antibiotics are good medicine for colds or flu..............................T F
5. Bacteria and viruses are pretty much the same.............................T F
6. It is OK to save some of your antibiotic prescription for the
next time that you are sick.......................................................... T F
7. When bacteria find a way to fight the antibiotic that you 
are taking, and your infection won't go away, this is called 
resistance T F
8. Our society does not have a bacterial resistance problem T F
9. You should not share your antibiotic with anyone else.................T F
10. Most common colds are caused by viruses................................. T F
Thank you for your participation.
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ANTIBIOTIC FACTS RESISTANCE FACTS FREQUENTLY 
ASKED QUESTIONS
What are antibiotics?
Antibiotics are prescription drugs that help 
your body fight ofFbacterial infection.
What are bacteria?
Bacteria are germs called organisms. Most 
bacteria are helpfUl; a few are harmful and 
cause illness.
Do antibiotics work against all 
infections? No. Antibiotics work in 
infections caused by bacteria. They don't 
work at all in infections caused by a virus, 
which is a different kind of organism..
What’s the difference between 
bacteria and viruses? Viruses cause 
colds, most coughs and sore throats. 
Infections caused by viruses cannot be 
cured with antibiotics. Bacterial 
infections can be cured by antibiotics.
What are some common infections 
antibiotics are prescribed for?
Antibiotics may be given for strep throat, 
ear infections, urinary tract infections, 
sinus infections and bronchitis.
What Is antibiotic resistance?
Sometimes bacteria find a way to fight the 
antibiotic you are taking and your infection 
won't go away. This is called antibiotic 
resistance.
What factors have contributed to 
antibiotic resistance?
* Incorrect use and overuse of antibiotics in 
humans, animals and farming.
* Failure to finish an antibiotic prescription. 
In some countries, antibiotics are available 
without a prescription.
* Patient demand for and receiving 
antibiotics when they are not called for.
* Overuse of anti-bacterial soaps.
How does antibiotic resistance affect me?
It is a very serious problem for everyone. You 
can be sicker for longer, and without knowing it 
you may have developed a dangerous form of 
resistant bacteria. Some of these resistant 
forms don't have any antibiotics that will work 
against them. This places all of us at risk for 
epidemics of bacterial disease where modem 
medicine may be powerless.
When should I take antibiotics?
You should take them when your 
doctor prescribes them for you
Can I save some of the antibiotic 
for the next time I am sick? No.
Left over antibiotics are not a 
complete dose. A complete dose of 
the antibiotic is needed to kill all the 
harmful bacteria.
m
When I start feeling better can I 
stop taking the antibiotic? No.
Your prescription is written to cover 
the time needed to help your body 
fight all the harmful bacteria. If you 
stop your medication early, the 
bacteria that have not yet been killed 
can restart an infection.
If I forget a dose or two is that a 
problem? Yes. These dmgs need to 
be taken on a frequent and consistent 
basis to achieve the best effect. If you 
don't take your medication as 
prescribed, the bacteria may not be 
killed and your illness may not 
improve.
Appendix C
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Gr an dXàlley
SCfVTEUsiIVERaTY
I CAMPUSDRiVE • ALLENDALE.MICHIGAN49401-9403 - 6 16/895-66If
February 18,1999
Karen Niemchick 
3946 Shorewood Ct 
Grandville, MI 49418
Dear Karen:
Your proposed project entitled "The Effects of Antibiotic and Resistance Education 
on Patient Knowledge" has been reviewed. It has been approved as a study which is 
exempt from the regulations by section 46.101 of the Federal Register 46(16):8336, 
January 26,1981.
Sincerely,
Paul Huizenga, Chair
Human Research Review Committee
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